Infection with high risk Human papillomavirus (HR-HPV) is necessary but not sufficient to cause cervical carcinoma. This study explored whether multiple HR-HPV or coinfection with Epstein-Barr virus (EBV) influence the integration status of HPV16 genome. The presence and typing of HPV in a series of 125 cervical specimens were assessed by polymerase chain reaction (PCR) using the specific primers for the HPV L1 region. As for EBV infection, the viral EBNA1 gene was used for its detection through PCR amplification. Disruption of the HPV E2 gene was assessed by amplification of the entire E2 gene with single set of primers, while E2 transcripts were evaluated by a reverse transcription PCR method (RT-PCR).
women will become infected with HPV during their lifetime but only a minority of these infections will progress to invasive cancers. Therefore, there is a continuing need for the identification of viral and host factors that modulate the risk of disease progression (11) . Possible agents included Herpes viruses among which more recently Epstein-Barr Virus (EBV), have been suspected to participate in cervical carcinogenesis (15, 33, 31, 13) . For example, latent infection with EBV has been shown to act as a carcinogenic cofactor in several epithelial cell malignancies (38) . The viral EBNA1 regulator of EBV transcription and replication is typically expressed in most forms of EBV-positive malignancies (24) . On the other hand, integration of HPV DNA into the human genome is considered an essential step in the progression of HPVassociated cervical infection to invasive cervical carcinoma (18, 41) . Upon integration the viral E2 gene, encoding a transcriptional repressor, is often disrupted with loss of its repressor function thus leading to up regulation of the transcription of the E6 and E7 oncogenes (30, 12) . High expression of the viral oncogenes leads to disturbance of cell cycle controls and genomic instability that increase the risk of malignant transformation (25, 29) . The main goal of our study was to explore frequency distribution of HR HPV genotypes and EBV infection in cervical cancer and premalignant lesions in order to correlate them with HPV 16 physical state.
MATERIALS AND METHODS

Sample Collection and Study Population
This study enrolled 44 patients with cervical carcinoma recruited from the Radio-oncology department of Salah Azaiez Institute (Tunis, Tunisia). The mean patient age was 57.2 years 
DNA and RNA isolation
DNA extraction was performed using the QIAamp system, QIAamp DNA Mini Kit (Qiagen, Hilden, Germany), according to standard procedures as described in the kit, with detergent lysis buffer and proteinase K digestion. Total DNA was eluted in 100 µl of elution buffer and stored frozen at -20°C. RNA from frozen tissues was isolated using RNeasy Mini Kit (Qiagen, Hilden, Germany) as recommended by the supplier and dissolved in 30µl RNase free water.
The quality and quantity of the target nucleic acids were assessed by agarose gel electrophoresis and optical density measurement (absorbance at 260 nm).
HR-HPV typing and EBV detection
Purified genomic DNA was amplified using PCR technique for the HR HPVL1 and EBV EBNA1 genes (synthesized by GeneCust Europe, Dudelange, Luxembourg) using specific primers, as well as for the internal reference β-globin gene, to determine whether the isolated DNA was suitable for amplification. Thermal cycles were performed in a programmable PCR thermal cycler (Applied Biosystem, Foster City, USA), as previously described (46, 21) . Each PCR experiment was performed with positive (HPV plasmids, cervical carcinoma previously proved to contain EBV) and negative (Blank water) controls. Samples tested positive for the Kahla, S. e t a l .
Correlation between EBV co-infection and HPV16 genome β-globin DNA control, confirming that none of the samples was inhibitory for PCR or lacked DNA. The Primer sequences, amplicon sizes and cycling programs are illustrated in Table 1 . Table 1 . Polymerase Chain Reaction and Reverse Transcription primers, product length and programs.
Assessment of HPV16 E2 DNA and RNA integrity
Adapting an approach previously described (4), the integrity of E2 gene was assessed using a single set of sequence-specific primers that were designed to amplify Open
Reading Frame (ORF) fragments spanning the full length of HPV16 E2 gene ( Table 1 ).
All positive samples for HPV 16 L1 expression were subjected to PCR amplification of the E2 ORF region. The presence of E2 amplicon in agarose gel confirmed an intact E2
gene, while lack of specific band indicated disruption. HPV16
positive samples were further subjected to amplification of E2 transcripts (28) . To control RNA integrity, RT-PCR reactions using β-actin specific primers were performed (34) . One microgram total RNA was reverse-transcribed using the one β Actin anti-sense 5'-TTGGCGTACAGGTCTTTGC-3' 500 94°C 30s, 50°C 30s, 72°C 1' ; X 30 Correlation between EBV co-infection and HPV16 genome Vista. The associations between the variables were assessed using Fisher's exact test. Odds Ratios (OR) and corresponding 95% Confidence Intervals (CI) were estimated by logistic regression models. A stepwise logistic regression analysis was used to assess the simultaneous effect of more than one variable and to identify for possible confounding factors. In all analyses, probability values less than 0.05 were regarded as significant.
RESULTS
Frequencies of HR-HPV DNA and EBV in cervical samples
By using the primers directed against the highly conserved Among the control group, no viral infection was detected. The results of HPV typing are summarized in Table 2 .
Our results indicate a significant increase in detection of HR-HPV in cancers compared to non malignant samples (P < 0.01).
The detection rate of EBV EBNA1 in tissue samples from cervical cancer patients was more frequent than that in non malignant samples (29.5% vs, 9.6 %, P = 0.01). In addition, EBV EBNA1 was not found in any of the control samples. 0.004* Correlation between EBV co-infection and HPV16 genome control, which was included to avoid false-negative results due to degradation of RNA (not shown). HPV16 E2 mRNAs were expressed in the presence of the intact virus with episomal forms and E2 transcripts originate only from the episomal HPV16 DNA. In Figure 1A and Figure 1B (Figure 1 A, Figure 1B) . In conclusion of our analysis, EBV may play a cooperative role in HPV16 carcinogenic progression by favoring HPV16 DNA integration in the cellular genome. phosphate-buffered saline; HPV: human papillomavirus.
